RYAM - Rayonier Advanced Materials Inc.
NYSE
->
Basic Materials
->
Chemicals
Jacksonville,
United States
Type: Equity
RYAM price evolution
RYAM
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $114.15 | $54.61 | $75.77 | |
| Short term investments | ||||
| Net receivables | $196.09 | $203.54 | $183.05 | $197.46 |
| Inventory | $234.03 | $225.47 | $228.05 | $207.47 |
| Total current assets | $629.01 | $634.95 | $545.56 | $575.06 |
| Long term investments | ||||
| Property, plant & equipment | $1053.93 | $1056.94 | $1057.89 | $1075.11 |
| Goodwill & intangible assets | $13.91 | $15.66 | $17.41 | |
| Total noncurrent assets | $1562.02 | $1589.49 | $1607.64 | |
| Total investments | ||||
| Total assets | $2159.36 | $2196.97 | $2135.05 | $2182.7 |
| Current liabilities | ||||
| Accounts payable | $166.93 | $186.01 | $157.7 | $186.23 |
| Deferred revenue | ||||
| Short long term debt | $25 | $23.06 | $25.28 | |
| Total current liabilities | $363.86 | $376.6 | $332.49 | $375.83 |
| Long term debt | $747.67 | $752.75 | $755.63 | $752.17 |
| Total noncurrent liabilities | $1065.24 | $1060.81 | $1060.42 | |
| Total debt | $777.75 | $778.68 | $777.46 | |
| Total liabilities | $1426.65 | $1441.84 | $1393.3 | $1436.25 |
| Shareholders' equity | ||||
| Retained earnings | $349.81 | $382.41 | $371.02 | $372.59 |
| Other shareholder equity | -$41.3 | -$49.88 | -$50.37 | -$45.92 |
| Total shareholder equity | $755.13 | $741.75 | $746.45 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $75.77 | $151.8 | $253.31 | $93.65 |
| Short term investments | $38.51 | |||
| Net receivables | $197.46 | $212.72 | $181.6 | $179.21 |
| Inventory | $207.47 | $265.33 | $230.69 | $233.48 |
| Total current assets | $575.06 | $689.53 | $776.12 | $633.57 |
| Long term investments | ||||
| Property, plant & equipment | $1075.11 | $1166.89 | $1146.16 | $1274.94 |
| Goodwill & intangible assets | $17.41 | $24.42 | $31.43 | $38.44 |
| Total noncurrent assets | $1607.64 | $1658 | $1668.9 | $1896.29 |
| Total investments | $38.51 | |||
| Total assets | $2182.7 | $2347.53 | $2445.02 | $2529.86 |
| Current liabilities | ||||
| Accounts payable | $186.23 | $163.96 | $169.46 | $156.72 |
| Deferred revenue | ||||
| Short long term debt | $25.28 | $14.62 | $37.68 | $17.1 |
| Total current liabilities | $375.83 | $353.68 | $354.56 | $293 |
| Long term debt | $752.17 | $838.51 | $891.03 | $1066.84 |
| Total noncurrent liabilities | $1060.42 | $1164.54 | $1276.12 | $1541.78 |
| Total debt | $777.46 | $853.13 | $928.71 | $1083.94 |
| Total liabilities | $1436.25 | $1518.21 | $1630.68 | $1834.78 |
| Shareholders' equity | ||||
| Retained earnings | $372.59 | $474.42 | $489.34 | $422.93 |
| Other shareholder equity | -$45.92 | -$63.8 | -$84.47 | -$133.63 |
| Total shareholder equity | $746.45 | $829.31 | $814.34 | $695.09 |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $401.1 | $419.05 | $387.66 | $422.49 |
| Cost of revenue | $370.74 | $350.89 | $395.13 | |
| Gross Profit | $43.57 | $48.31 | $36.76 | $27.35 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $21.81 | $21.07 | $17.06 | |
| Total operating expenses | $25.55 | $20.67 | $22.6 | $86.83 |
| Operating income | $27.64 | $14.16 | -$59.47 | |
| Income from continuing operations | ||||
| EBIT | $31.81 | $18.81 | -$60.81 | |
| Income tax expense | -$4.59 | -$0.85 | -$0.47 | -$21.08 |
| Interest expense | -$22.31 | $21.27 | $20.86 | $21.86 |
| Net income | ||||
| Net income | -$32.6 | $11.39 | -$1.57 | -$61.59 |
| Income (for common shares) | $11.39 | -$1.57 | -$61.59 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1643.33 | $1717.27 | $1407.56 | $1738.9 |
| Cost of revenue | $1555.18 | $1594.18 | $1332.84 | $1601.12 |
| Gross Profit | $88.15 | $123.08 | $74.72 | $137.78 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $75.71 | $91.47 | $75.79 | $85.19 |
| Total operating expenses | $150.42 | $101.67 | $86.04 | $110.71 |
| Operating income | -$62.27 | $21.41 | -$11.32 | $27.07 |
| Income from continuing operations | ||||
| EBIT | -$60.34 | $52.17 | $98.12 | $18.16 |
| Income tax expense | -$32.31 | $0.9 | -$34.69 | -$46.61 |
| Interest expense | $73.81 | $66.18 | $66.39 | $64.21 |
| Net income | ||||
| Net income | -$101.83 | -$14.92 | $66.41 | $0.56 |
| Income (for common shares) | -$101.83 | -$14.92 | $66.41 | $0.56 |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $11.39 | -$1.57 | -$61.59 | |
| Operating activities | ||||
| Depreciation | $33.51 | $33.28 | $35.91 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.69 | $1.78 | $1.15 | |
| Total cash flows from operations | $87.59 | $11.27 | $54.13 | |
| Investing activities | ||||
| Capital expenditures | -$25.46 | -$32.56 | -$32.47 | |
| Investments | ||||
| Total cash flows from investing | -$79.67 | -$25.46 | -$32.56 | -$31.66 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.19 | -$0.45 | -$0.06 | |
| Net borrowings | -$1.84 | $1.38 | $24.88 | |
| Total cash flows from financing | -$9.98 | -$2.03 | $0.93 | $24.82 |
| Effect of exchange rate | $1.28 | -$0.56 | -$0.79 | $1.34 |
| Change in cash and equivalents | $60.32 | $60.1 | -$20.37 | $47.3 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$101.83 | -$14.92 | $66.41 | $0.56 |
| Operating activities | ||||
| Depreciation | $139.98 | $134.58 | $138.3 | $151.46 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.51 | $9.65 | $5.1 | $6.6 |
| Total cash flows from operations | $136.27 | $68.81 | $233.22 | $124.47 |
| Investing activities | ||||
| Capital expenditures | -$127.67 | -$138.22 | -$93.22 | -$73.39 |
| Investments | ||||
| Total cash flows from investing | -$127.28 | -$94.17 | $85.39 | -$77.82 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$5.42 | -$0.43 | -$1.42 | -$0.46 |
| Net borrowings | -$81.53 | -$72.68 | -$155.24 | -$18.93 |
| Total cash flows from financing | -$86.95 | -$73.11 | -$156.66 | -$19.39 |
| Effect of exchange rate | $1.92 | -$3.03 | -$2.3 | $2.37 |
| Change in cash and equivalents | -$77.95 | -$98.48 | $161.95 | $27.26 |
News
Fundamentals
| Market cap | $328.16M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 65.90M |
| Revenue | $1.63B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$84.37M |
| Revenue Q/Q | 8.80% |
| Revenue Y/Y | -5.26% |
| P/E ratio | -3.89 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.20 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$1.28 |
|---|---|
| ROA | -3.89% |
| ROE | N/A |
| Debt/Equity | 1.92 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.73 |
| Quick ratio | 1.09 |